Skip to content

Mentions in the Press

Highlighting Our Clients' Media Coverage

See how our clients are making headlines with impactful stories and expert insights featured in top-tier media outlets.

The Next Evolution of Psychedelic Medicine May Not Be Psychedelic at All

As clinical research advances beyond first-generation compounds, scientists are rethinking what psychedelic-inspired therapies could look like and how they may reshape the future of mental healthcare. For decades, psychedelic compounds occupied the fringes of medical research. Today, they’re at the center of one of the most active areas of neuroscience. From psilocybin and LSD to […]

Read Now

New antidepressants: Tackling treatment resistant depression

Enveric’s lead candidate, EB-003, is a novel neuroplastogen that engages both the 5-HT2A and 5-HT1B receptors, a dual mechanism that may define a new class of neuropsychiatric treatments. This pharmacological profile is designed to promote adaptive rewiring of brain circuits while stabilizing emotional and behavioral regulation, potentially enabling durable recovery in patients with post-traumatic stress disorder (PTSD), treatment-resistant […]

Read Now

Executive Order For Psychedelics

A conversation with Joseph Tucker, Ph.D., CEO, Enveric Biosciences. The White House recently issued an executive order accelerating the use of psychedelics, such as psilocybin, MDMA, and ibogaine, in research and clinical trials. This order, however, does not change the current legal status of any of them.

Read Now

Enveric Highlights Preclinical PTSD Data Amid Rising Focus On Mental Health Therapies

Enveric Biosciences Inc. (NASDAQ:ENVB) on Tuesday highlighted preclinical findings for its lead candidate EB-003. It pointed to rapid reductions in PTSD-related fear responses, as recent federal policy signals growing support for psychedelic-based mental health treatments.

Read Now

Executive Order For Psychedelics

The White House recently issued an executive order accelerating the use of psychedelics, such as psilocybin, MDMA, and ibogaine, in research and clinical trials. This order, however, does not change the current legal status of any of them.

Read Now

FDA Fast-Tracks Review of Psychedelic Drugs for Mental Health Treatment

The U.S. FDA has fast-tracked the review of three psychedelic drugs being developed to treat depression, PTSD, and other mental health conditions. CGTN’s Sean Callebs spoke with Dr. Robert Discordia, Co-Founder and CEO of Equulus Therapeutics, about the science, the politics, and what accelerated approval could mean for patients.

Read Now

Latin America And The New Geopolitics Of Mining

After more than two years offline, Panama’s largest copper mine is edging back into the global supply conversation. In January, Panamanian President José Raúl Mulino said he expects to announce by June the government’s decision whether or not to reopen Cobre Panama. A full reopening would restore a major source of copper to a constrained […]

Read Now

EXCLUSIVE: Inside Kylie Jenner’s more muted look as she seemingly has fillers dissolved

The 28-year-old beauty mogul has worn some stunning dresses already this year, such as a custom ruby red Schiaparelli gown featuring a signature “keyhole” cutout and a plunging neckline to the Oscars, and a custom gold sequin Ashi Studio gown with a sweetheart neckline, which made Kylielook like a glittering trophy.

Read Now

Hope For Non-Hallucinogenic Neuroplastogens

Non-hallucinogenic neuroplastogens are being developed as a potentially safer alternative to psychedelics, with a lower risk of hallucinations. Enveric Biosciences is developing a derivative designed to preserve signaling associated with therapeutic neuroplasticity while potentially reducing hallucinogenic risk.

Read Now

Demi Moore Sparks Fresh Concern Over ‘Skinnier-Than-Ever’ Appearance at Actor Awards — ‘Food Must Be Very Expensive in L.A.’

While plastic surgery experts noted genetics play a key role in individual aging, they suggested Moore’s fresh face could also be attributed to a strict routine of advanced cosmetic treatments. Dr. Tia Liu, MD MSc, who has not personally treated the actress, told RadarOnline.com the “uniform luminosity people notice typically comes from consistent medical grade […]

Read Now